胰淀素
受体
降钙素
肽
降钙素受体
化学
表型
生物化学
内分泌学
生物
基因
降钙素基因相关肽
神经肽
小岛
胰岛素
作者
Jianjun Cao,Matthew J. Belousoff,Yi-Lynn Liang,Rachel M. Johnson,Tracy M. Josephs,Madeleine M. Fletcher,Arthur Christopoulos,Debbie L. Hay,Radostin Danev,Denise Wootten,Patrick M. Sexton
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2022-03-24
卷期号:375 (6587)
被引量:40
标识
DOI:10.1126/science.abm9609
摘要
Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity–modifying proteins (RAMPs), AMY 1 R, AMY 2 R, and AMY 3 R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY 1 R with salmon CT (sCT), AMY 2 R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI